SHAWNA JOHNSON: Open Payments
NPI 1215445457 · MCPHERSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 21 payments from 12 companies in 2025. Trend: 2023 $584 · 2024 $466 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $78 |
| Lilly USA, LLC | 4 | $67 |
| ABBVIE INC. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Insulet Corporation | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Globus Medical, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: GEMTESA, MOUNJARO, VRAYLAR, CAPLYTA, ZENPEP, QULIPTA, Omnipod, BREZTRI.
Industry payments across KS — which companies pay providers there.
